HomeCompareIBXNF vs ADC

IBXNF vs ADC: Dividend Comparison 2026

IBXNF yields 200.00% · ADC yields 4.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IBXNF wins by $119.19M in total portfolio value
10 years
IBXNF
IBXNF
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full IBXNF calculator →
ADC
Agree Realty Corporation
● Live price
4.11%
Share price
$75.38
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.9K
Annual income
$79,647.25
Full ADC calculator →

Portfolio growth — IBXNF vs ADC

📍 IBXNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIBXNFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IBXNF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IBXNF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBXNF
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
ADC
Annual income on $10K today (after 15% tax)
$349.45/yr
After 10yr DRIP, annual income (after tax)
$67,700.16/yr
At 15% tax rate, IBXNF beats the other by $51,081,981.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBXNF + ADC for your $10,000?

IBXNF: 50%ADC: 50%
100% ADC50/50100% IBXNF
Portfolio after 10yr
$59.77M
Annual income
$30,127,871.76/yr
Blended yield
50.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

IBXNF
No analyst data
Altman Z
5.4
Piotroski
6/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+7.5% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBXNF buys
0
ADC buys
0
No recent congressional trades found for IBXNF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIBXNFADC
Forward yield200.00%4.11%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$119.36M$176.9K
Annual income after 10y$60,176,096.29$79,647.25
Total dividends collected$112.49M$154.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: IBXNF vs ADC ($10,000, DRIP)

YearIBXNF PortfolioIBXNF Income/yrADC PortfolioADC Income/yrGap
1← crossover$30,700$20,000.00$10,987$577.21+$19.7KIBXNF
2$90,232$57,383.18$12,293$855.34+$77.9KIBXNF
3$254,173$157,624.56$14,088$1,290.70+$240.1KIBXNF
4$686,927$414,961.74$16,660$1,994.91+$670.3KIBXNF
5$1,783,118$1,048,106.39$20,525$3,181.85+$1.76MIBXNF
6$4,450,613$2,542,677.12$26,654$5,286.90+$4.42MIBXNF
7$10,693,420$5,931,263.38$37,006$9,259.47+$10.66MIBXNF
8$24,760,608$13,318,648.86$55,862$17,338.74+$24.70MIBXNF
9$55,315,649$28,821,798.66$93,452$35,300.32+$55.22MIBXNF
10$119,363,841$60,176,096.29$176,931$79,647.25+$119.19MIBXNF

IBXNF vs ADC: Complete Analysis 2026

IBXNFStock

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Full IBXNF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this IBXNF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBXNF vs SCHDIBXNF vs JEPIIBXNF vs OIBXNF vs KOIBXNF vs MAINIBXNF vs NNNIBXNF vs EPRTIBXNF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.